Market News & Trends
Pfanstiehl Launches cGMP-Produced, Parenteral-Grade Mannitol for Pharmaceutical Formulations
Pfanstiehl has announced the launch of a new high purity, low endotoxin, Mannitol (USP/NF, EP, JP), manufactured in the US under strict cGMP, ICH Q7…
Acute Myeloid Leukemia Treatment Market to Witness Modest Growth by 2020
The value of the global Acute Myeloid Leukemia (AML) therapeutics market will increase moderately from $632.6 million in 2013 to $878.6 million by 2020, representing…
Charleston Laboratories & Daiichi Sankyo Initiate Two Phase III Trials
Charleston Laboratories, Inc. and their co-development and co-commercialization partner, Daiichi Sankyo, Inc., initiated two Phase III clinical trials on CL-108, Charleston Laboratories' lead product in…
BioNano Genomics Raises $53 Million to Advance Genomic Mapping Technology
BioNano Genomics, Inc. recently announced the completion of a $53-million Series C financing. Legend Capital and Novartis Venture Fund co-led the round and were joined…
Apellis Pharmaceuticals to acquire Potentia Pharmaceuticals
Apellis Pharmaceuticals recently announced it entered into an agreement to acquire Potentia Pharmaceuticals. As part of the acquisition agreement, Apellis obtained the necessary intellectual property…
Nicox's US Ophthalmic Diagnostics Subsidiary Bought for $20 Million
Nicox S.A. recently announced that Valeant Pharmaceuticals International, Inc. has acquired Nicox’s US diagnostics subsidiary Nicox Inc., in a deal worth up to $20 million.…
Global Market for miRNA Research Tools, Diagnostics & Therapeutics to Reach $1 Billion by 2019
Wellesley, Mass., November 24, 2014 – BCC Research (www.bccresearch.com) reveals in its new report, MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets, the global market…
Knight Sells priority Review Voucher for $125 Million
Knight Therapeutics Inc., through one of its wholly owned subsidiaries, recently announced the sale of its Neglected Tropical Disease Priority Review Voucher (PRV). The PRV…
Horizon Discovery Group & Adarza BioSystems Enter Supply & Licensing Agreement
Cambridge, UK, and St. Louis, MO, 24th November 2014 – Horizon Discovery Group plc (LSE:HZD), a leading provider of research tools to support translational genomics…
Vetter Announces Opening of Office to support Growing Asian Healthcare Market
Vetter recently announced the opening of a new representative office in Singapore. The announcement was made at a ceremony attended by members of local government…
Despite Patent Cliffs, Pharmaceutical Market Shows Signs of Stability
The pharmaceutical market is beginning to show signs of stability, with a review of 30 leading companies highlighting combined revenues of $718.7 billion in 2013,…
EMD Millipore Introduces New Virtual Conference: "5-Star LC-MS Practices"
EMD Millipore Introduces New Virtual Conference: "5-Star LC-MS Practices" Darmstadt, Germany - November 18, 2014 - EMD Millipore, the Life Science division of Merck KGaA of…
AVEO Enters Agreement With Ophthotech for Ocular Diseases
AVEO Oncology recently announced it has entered into a research and exclusive option agreement with Ophthotech Corporation, under which it has provided Ophthotech an exclusive…
West Receives 510(k) Clearance for NovaGuard SA Safety System
West Pharmaceutical Services, Inc. recently announced that the NovaGuard SA (Staked-needle Automatic) safety system has received 510(k) clearance from the US FDA. The NovaGuard SA…
EMD Millipore’s 12 Flow Cytometer Offers Improved Resolution
EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, offers new data demonstrating improved performance for its guava easyCyte 12 flow cytometer,…
Onxeo Confirms Receipt of $25-Million Milestone Payment
Onxeo SA, an innovative company specializing in the development of orphan oncology drugs, recently announced it has received from his US partner Spectrum Pharmaceuticals the…
Geron Announces $935-Million Global Strategic Collaboration With Janssen
Geron Corporation recently announced it has entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech, Inc. to develop and commercialize, imetelstat, Geron's…
Valeant Pharmaceuticals Completes Renovation of US Headquarters in New Jersey
Valeant Pharmaceuticals International, Inc. recently celebrated the completion of renovations to its US headquarters in Bridgewater, NJ, with a ribbon-cutting ceremony. The ceremony, which was…
Medidata Teams Up With Mundipharma Research to Move Clinical Research to the Cloud
NEW YORK, N.Y. – November 5, 2014 – Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology for clinical research in life sciences, recently announced…
Catalent Adds Global Particle Size Technology Leader to Industry’s Broadest Bioavailability & Delivery Technology Offerings
Somerset, N.J. – November 13, 2014 — Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics…
